Frequency of nonresponse antiplatelet activity of Clopidogrel during pretreatment for cardiac catheterization

American Journal of Cardiology

Volumn 93, Issue 4, 2004, Pages 456-458

  Mobley, Joseph E ^a   Bresee, Stuart J ^a   Wortham, Dale C ^a   Craft, Robert M ^a   Snider, Carolyn C ^a   Carroll, Roger C ^a  

^a UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; ATORVASTATIN; CLOPIDOGREL;

ADULT; AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HUMAN; INTRACARDIAC THROMBOSIS; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOELASTOGRAPHY; TREATMENT FAILURE; TREATMENT INDICATION;

EID: 1242315475     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.10.042     Document Type: Article

References (8)

1. Kaufman J.S., Fiore L., Hasbargen J.A., O'Connor T.Z., Perdriset G. A pharmacodynamic study of clopidogrel in chronic hemodialysis patients. J Thromb Thrombolysis. 10:2000;127-131.
2. Järemo P., Lindahl T.L., Fransson S.G., Richter A. Individual variations of platelet inhibition after loading doses of clopidogrel. J Intern Med. 252:2002;233-238.
3. Lau W.C., Waskell L.A., Watkins P.B., Neer C.J., Horowitz K., Hopp A.S., Tait A.R., Carville D.G., Guyer K.E., Bates E.R. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation a new drug-drug interaction . Circulation. 107:2003;32-37.
4. Serebruany V.L., Steinhubl S.R., Hennekens C.H. Are antiplatelet effects of clopidogrel inhibited by atorvastatin? A research question formulated but not yet adequately tested. Circulation. 107:2003;1568-1569.
5. Gurbel P.A., Cummings C.C., Bell C.R., Alford A.B., Meister A.F., Serebruany V.L. Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial . Am Heart J. 145:2003;239-247.
6. Gurbel P.A., Bliden K.P., Hiatt B.L., O'Connor C.M. Clopidogrel for coronary stenting response variability, drug resistance, and the effect of pretreatment platelet reactivity . Circulation. 107:2003;2908-2913.
7. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 345:2001;494-502.
8. Born G.V.R. Quantitative investigation into the aggregation of blood platelets. J Physiol. 16:1962;67-68.